Journal of Clinical Endocrinology & Metabolism, Vol 61, 639-643, Copyright © 1985 by Endocrine Society

ARTICLES

Evidence from monoclonal antibody studies that insulin stimulates deoxyribonucleic acid synthesis through the type I somatomedin receptor

JJ Van Wyk, DC Graves, SJ Casella and S Jacobs

Somatomedin-C/insulin-like growth factor-I (Sm-C/IGF-I) and insulin stimulate DNA synthesis and cell replication in cultured human fibroblasts. It has been postulated that the growth-promoting actions of both peptides are mediated through the type I Sm-C/IGF-I receptor. This study tests this hypothesis using two recently developed monoclonal antibodies. The antibody designated sm 1.2 is directed to Sm- C, whereas the antibody designated alpha IR-3 is directed against the type I receptor for Sm-C/IGF-I. Radiolabeled monoclonal antibody alpha IR-3 was bound to human foreskin fibroblasts in a reversible time- dependent fashion, with 90% of the specific binding complete after 6 h of incubation at 15 C. Binding of [125I]alpha IR-3 was completely inhibited by excess unlabeled antibody, but not by 50 nM Sm-C or 1000 nM insulin. Specific binding of [125I]Sm-C fell to 27% of the control value in the presence of 50 nM alpha IR-3, and this concentration of antibody significantly reduced the mitogenic response to both Sm-C and insulin. Antibody sm 1.2 blocked the mitogenic response to exogenous Sm- C, but did not block the response to insulin; indeed, in some experiments, sm 1.2 enhanced the response to insulin. We postulate that this enhancement is the result of neutralizing endogenously produced Sm- like substances. This study provides further evidence that the growth- promoting effects of insulin in this cell type are the result of interaction with the Sm-C/IGF-I receptor.

This article has been cited by other articles:

				T. T. Tran, D. Naigamwalla, A. I. Oprescu, L. Lam, G. McKeown-Eyssen, W. R. Bruce, and A. Giacca Hyperinsulinemia, But Not Other Factors Associated with Insulin Resistance, Acutely Enhances Colorectal Epithelial Proliferation in Vivo Endocrinology, April 1, 2006; 147(4): 1830 - 1837. [Abstract] [Full Text] [PDF]

				K. R. JESSEN and R. MIRSKY Why Do Schwann Cells Survive in the Absence of Axons? Ann. N.Y. Acad. Sci., September 14, 1999; 883(1): 109 - 115. [Abstract] [Full Text] [PDF]

				C. Meier, E. Parmantier, A. Brennan, R. Mirsky, and K. R. Jessen Developing Schwann Cells Acquire the Ability to Survive without Axons by Establishing an Autocrine Circuit Involving Insulin-Like Growth Factor, Neurotrophin-3, and Platelet-Derived Growth Factor-BB J. Neurosci., May 15, 1999; 19(10): 3847 - 3859. [Abstract] [Full Text] [PDF]

				T. A. Hillier, D. A. Fryburg, L. A. Jahn, and E. J. Barrett Extreme hyperinsulinemia unmasks insulin's effect to stimulate protein synthesis in the human forearm Am J Physiol Endocrinol Metab, June 1, 1998; 274(6): E1067 - E1074. [Abstract] [Full Text] [PDF]

				J. O'Prey, N. Leslie, K. Itoh, W. Ostertag, C. Bartholomew, and P. R. Harrison Both Stroma and Stem Cell Factor Maintain Long-Term Growth of ELM Erythroleukemia Cells, but Only Stroma Prevents Erythroid Differentiation in Response to Erythropoietin and Interleukin-3 Blood, March 1, 1998; 91(5): 1548 - 1555. [Abstract] [Full Text] [PDF]

				J. W. Kolaczynski and J. F. Caro Insulin-like Growth Factor-1 Therapy in Diabetes: Physiologic Basis, Clinical Benefits, and Risks Ann Intern Med, January 1, 1994; 120(1): 47 - 55. [Abstract] [Full Text]